Three Rutgers University researchers seek to address important gaps in understanding not only the cognitive, neural, and immunological consequences of COVID-19 in older African Americans but also how those consequences can impact this population’s risk for Alzheimer’s Disease.
Rutgers Robert Wood Johnson Medical School (RWJMS) is projected to receive approximately $30 million, establishing a critical partnership with the larger National Institutes of Health-funded RECOVER initiative to study long-term and delayed impacts of COVID-19 in children and lead a national collaboration with the potential to recruit from any state to investigate these outcomes.
Nearly 1 in 5 people in the United States over the age of 12 haven’t gotten at least one shot. Some may be reluctant to take a vaccine they believe has only been tested for a few months, but that couldn’t be further from the truth, says Michelle Carlin, an assistant professor of forensic chemistry at Rutgers University–Camden.
Rutgers, a clinical trial site for the global Pfizer-BioNTech research study to evaluate the efficacy of its COVID-19 vaccine in children, is looking for participants for a third clinical trial on children ages 6 months to 4 years.
COVID-19 saliva testing kits that include a novel preservative can also be used to measure microscopic organisms in the mouth, a Rutgers study found.
Rutgers researchers studying COVID-19 have created a new way to deliver DNA molecules into skin cells, using a suction technique similar to the ancient healing practice of cupping that increases blood circulation and promotes healing.
People who rely exclusively on Facebook for news and information about the coronavirus are less likely than the average American to have been vaccinated, according to a new survey.